$ALDX
Aldeyra Therapeutics Inc
PRICE
$2.8 ▲0.719%
Delayed Price
VOLUME
6,567
DAY RANGE
- 2.8
52 WEEK
1.42 - 11.97
Key Metrics
Market Cap
163.73 M
Beta
1.28
Avg. Volume
551.95 K
Shares Outstanding
58.90 M
Yield
0%
Public Float
0
Next Earnings Date
2024-05-02
Next Dividend Date
Company Information
dedicated to improving lives by developing products that treat aldehyde-mediated diseases. we are a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes. we are developing adx-102 (formerly ns2), as well as other novel product candidates that are designed specifically to sequester aldehydes, for the treatment of: • noninfectious anterior uveitis, a rare severe inflammatory eye disease that can lead to blindness; • allergic conjunctivitis, a common disease that affects more than 20% of the population worldwide, and related rare allergic ocular diseases that are characterized by inflammation of the conjunctiva (a membrane covering part of the front of the eye), resulting in ocular itching, excessive tear production, swelling, and redness; • dry eye disease, a common inflammatory dise
Website: aldeyra.com
HQ: ,
Related News